Covered recipient · General Payments record
BRUCE PHILLIP ROBINSON
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$5,452.55
- Reported across 310 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $609.75 | 34 |
| Education | $72.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $264.82 | 18 |
| Janssen Biotech, Inc. | $97.99 | 2 |
| PFIZER INC. | $80.56 | 4 |
| GENZYME CORPORATION | $75.60 | 3 |
| Almirall LLC | $44.00 | 3 |
| Lilly USA, LLC | $34.80 | 1 |
| Dermavant Sciences, Inc. | $26.57 | 1 |
| Verrica Pharmaceuticals Inc. | $22.29 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.31 | 1 |
| Galderma Laboratories, L.P. | $16.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.21 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959350 | CMS |
| ABBVIE INC. | $27.52 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959352 | CMS |
| ABBVIE INC. | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959354 | CMS |
| ABBVIE INC. | $5.58 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959356 | CMS |
| ABBVIE INC. | $2.05 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959358 | CMS |
| ABBVIE INC. | $11.11 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959360 | CMS |
| ABBVIE INC. | $20.54 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959362 | CMS |
| ABBVIE INC. | $6.30 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959364 | CMS |
| ABBVIE INC. | $18.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959366 | CMS |
| ABBVIE INC. | $21.40 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959368 | CMS |
| ABBVIE INC. | $18.46 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959370 | CMS |
| ABBVIE INC. | $12.76 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959372 | CMS |
| ABBVIE INC. | $32.12 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959374 | CMS |
| ABBVIE INC. | $12.67 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959376 | CMS |
| ABBVIE INC. | $0.91 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959378 | CMS |
| ABBVIE INC. | $6.11 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959380 | CMS |
| ABBVIE INC. | $9.51 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959382 | CMS |
| ABBVIE INC. | $19.88 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959384 | CMS |
| Almirall LLC | $14.40 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120645651 | CMS |
| Almirall LLC | $15.41 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120645679 | CMS |
| Almirall LLC | $14.19 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120645675 | CMS |
| Dermavant Sciences, Inc. | $26.57 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127924581 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.31 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101418839 | CMS |
| Galderma Laboratories, L.P. | $16.81 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145324153 | CMS |
| GENZYME CORPORATION | $24.90 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139623919 | CMS |
| GENZYME CORPORATION | $23.91 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139623957 | CMS |
| GENZYME CORPORATION | $26.79 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139623995 | CMS |
| Janssen Biotech, Inc. | $72.00 | 08/28/2024 | Education | Undisputed | 01/23/2026 | 1078450867 | CMS |
| Janssen Biotech, Inc. | $25.99 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078444548 | CMS |
| Lilly USA, LLC | $34.80 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136077975 | CMS |
| PFIZER INC. | $22.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131287941 | CMS |
| PFIZER INC. | $17.87 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131289876 | CMS |
| PFIZER INC. | $20.42 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131777003 | CMS |
| PFIZER INC. | $19.41 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131204367 | CMS |
| Verrica Pharmaceuticals Inc. | $22.29 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118385846 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.